Literature DB >> 31648856

A cross-sectional survey of knowledge, attitudes, and practice in the prescription of isotretinoin for transgender patients among academic dermatologists.

Courtney J Ensslin1, Keshav Khanijow2, Gayane Yenokyan3, Manisha Loss4.   

Abstract

Entities:  

Year:  2019        PMID: 31648856      PMCID: PMC6886525          DOI: 10.1016/j.jaad.2019.05.088

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Transgender Patients, Isotretinoin, and US Food and Drug Administration-Mandated Risk Evaluation and Mitigation Strategies: A Prescription for Inclusion.

Authors:  Kenneth A Katz
Journal:  JAMA Dermatol       Date:  2016-05-01       Impact factor: 10.282

Review 2.  Prescribing isotretinoin in the United States for transgender individuals: Ethical considerations.

Authors:  Howa Yeung; Suephy C Chen; Kenneth A Katz; Benjamin K Stoff
Journal:  J Am Acad Dermatol       Date:  2016-09       Impact factor: 11.527

3.  Prescribing isotretinoin for transgender youth: A pledge for more inclusive care.

Authors:  Markus D Boos; Brian A Ginsberg; Jon Klint Peebles
Journal:  Pediatr Dermatol       Date:  2018-10-15       Impact factor: 1.588

4.  Transgender men who experienced pregnancy after female-to-male gender transitioning.

Authors:  Alexis D Light; Juno Obedin-Maliver; Jae M Sevelius; Jennifer L Kerns
Journal:  Obstet Gynecol       Date:  2014-12       Impact factor: 7.661

5.  Unforeseen ethical challenges for isotretinoin treatment in transgender patients.

Authors:  Shankar N Mundluru; Joshua D Safer; Allison R Larson
Journal:  Int J Womens Dermatol       Date:  2016-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.